Related Experiment Video
Updated: May 11, 2025

07:53
Author Spotlight: Improved Imaging for Neovascular Development in Congenital Heart Disease Research
Published on: April 26, 2024
461
Oversized Conduits Predict Stenosis in Tissue Engineered Vascular Grafts
Kevin M Blum1, Mackenzie E Turner2, Erica L Schwarz3
1Center for Regenerative Medicine, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
JACC. Basic to Translational Science
|April 17, 2025
Summary
Tissue-engineered vascular grafts (TEVGs) show promise for congenital heart disease. Proper graft sizing matching native vessels is crucial to prevent stenosis and improve TEVG performance.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Tissue-engineered vascular grafts (TEVGs) offer a solution for congenital heart disease repair using autologous tissue.
- Current TEVG strategies involve biodegradable scaffolds seeded with cells to form functional neovessels.
- Understanding factors influencing neovessel formation is critical for optimizing TEVG efficacy.
Purpose of the Study:
- To identify key factors influencing neovessel formation and stenosis development in thoracic TEVGs.
- To evaluate the impact of hemodynamics and surgical sizing on TEVG outcomes.
- To correlate preclinical findings with clinical data for improved TEVG design.
Main Methods:
- Evaluation of 50 ovine thoracic TEVGs using angiography at 1 and 6 weeks postimplantation.
- Nondimensionalization to account for anatomical variations and analyze hemodynamics.
- Regression analysis and computational fluid dynamics (CFD) to assess graft narrowing and wall shear stress.
Main Results:
- Narrowing at the inflow anastomosis and graft oversizing were significantly correlated with stenosis development.
- CFD analysis indicated that these factors alter wall shear stress and flow patterns, leading to neovessel narrowing.
- Findings were supported by comparisons with clinical data from Fontan conduit trials.
Conclusions:
- Surgical sizing and inflow hemodynamics are critical determinants of TEVG performance.
- Matching TEVG size to the native inflow vessel is essential for reducing stenosis.
- Optimizing graft sizing can enhance the clinical success of TEVGs in treating congenital heart disease.

